日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cell therapy in sarcoma: current landscape and future directions

肉瘤细胞疗法:现状与未来方向

Sahin, Taha Koray; Germetaki, Theodora; Guven, Deniz Can; Akin, Serkan; Dizdar, Omer; Thistlethwaite, Fiona; Connolly, Elizabeth A; Lim, Kok Haw Jonathan

Dermoscopic and Histopathological Features of Melanocytic Lesions in Melanoma Patients Undergoing Adjuvant Systemic Therapy

接受辅助全身治疗的黑色素瘤患者黑色素细胞病变的皮肤镜和组织病理学特征

Yalcin, Huseyin Berk; Balan, Kerem; Gokoz, Ozay; Elcin, Gonca; Dizdar, Omer; Kılıckap, Saadettin; Gulseren, Duygu

Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study

接受免疫检查点抑制剂治疗的长期生存者的健康相关生活质量和心理社会结局:一项全国多中心研究

Sahin, Taha Koray; Atalah, Fatih; Koylu, Bahadir; Oruc, Ahmet; Acarbay, Aydin; Karakok, Akgun; Dogan, Sevgi; Kikili, Cevat Ilteris; Turhan, Görkem; Emin, Gamze; Celik, Selahattin; Deliktas Onur, Ilknur; Tuzcu, Tuba Ugur; Biter, Sedat; Efil, Safa Can; Ardic, Fadime Sinem; Gokmen, Azer; Guzel, Halil Goksel; Turan, Kadri; Disli, Ahmet Kürsad; Tunbekici, Salih; Goker, Erdem; Inanc, Mevlude; Ozdemir, Ozlem; Ozturk, Banu; Urun, Muslih; Yasar, Hatime Arzu; Sendur, Mehmet Ali Nahit; Kara, Ismail Oguz; Sutcuoglu, Osman; Ates, Ozturk; Eren, Tulay; Yildirim, Atila; Kilickap, Saadettin; Dizdar, Omer; Turker, Fatma Alev; Erman, Mustafa; Artac, Mehmet; Selcukbiricik, Fatih; Aksoy, Sercan; Guven, Deniz Can

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8-year study of 10 754 patients in Turkey

土耳其一项对10754例转移性结直肠癌患者进行为期8年的研究评估了KRAS和NRAS突变在转移性结直肠癌中的分布情况。

Kavgaci, Gozde; Akiva, Izzet; Ozon, Yavuz Hakan; Berkil, Hakan; Karadayi, Huseyin; Dizdar, Omer; Yalcin, Suayib

FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG)

FOLFIRINOX方案:壶腹腺癌的最佳辅助治疗方案?土耳其肿瘤协作组(TOG)的多中心研究

Kalem, Ali; Kus, Tulay; Sahin, Taha Koray; Dizdar, Omer; Efil, Safa Can; Sendur, Mehmet Ali Nahit; Aykut, Talat; Araz, Murat; Bolek, Hatice; Urun, Yuksel; Sever, Nadiye; Bayoglu, Ibrahim Vedat; Cavdar, Eyyup; Sagıroglu, Muhammed Fatih; Gunes, Tugce Kubra; Ozcelik, Melike; Demirel, Nadide; Yıldız, Bulent; Karabuga, Berkan; Yalcıntas Arslan, Ulku; Gokcek, Savas; Unek, Ilkay Tugba; Saray, Seray; Aslan, Ferit; Acar, Omer; Erdogan, Atike Pınar; Seyyar, Mustafa; Aktas, Gokmen; Yalcın, Suayib

Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study

黑色素瘤辅助治疗和一线转移性治疗的预后因素和结果:土耳其肿瘤协作组研究

Majidova, Nargiz; Arak, Hacı; Ozalp, Faruk Recep; Bas, Onur; Koker, Gulhan Ozcelik; Ozmarasalı, Erkan Buket; Karateke, Yasemin Sagdıc; Sakalar, Teoman; Yaslikaya, Sendag; Onur, Ilknur Deliktas; Akdag, Goncagul; Ogul, Ali; Guliyev, Murad; Sahin, Elif; Delipoyraz, Ebru Engin; Alkan, Ali; Aydın, Okan; Ilhan, Nurullah; Alan, Ozkan; Akbas, Sinem; Cağlar, Yaprak; Guren, Ali Kaan; Sever, Nadiye; Ellez, Halil Ibrahim; Selcukbiricik, Fatih; Muhammed Atcı, Mustafa; Bilici, Ahmet; Demirci, Nebi Serkan; Basoglu, Tugba; Karacin, Cengiz; Kara, Ismail Oguz; Yıldız, Bulent; Evrensel, Turkkan; Karaca, Mustafa; Dizdar, Omer; Atag, Elif; Ozgun, Alpaslan; Kostek, Osman

Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study

系统性炎症标志物在PD-L1 CPS评分≥5的转移性胃癌和胃食管交界处腺癌患者中的预后和预测价值:土耳其肿瘤协作组(TOG)研究

Mildanoglu, Maral Martin; Kutlu, Yasin; Bas, Onur; Koylu, Bahadır; Dae, Shute Ailia; Sakin, Abdullah; Erdem, Dilek; Sendur, Mehmet Ali Nahit; Tasci, Elif Senocak; Dane, Faysal; Kaya, Ali Osman; Aykan, Musa Baris; Ergun, Yakup; Biter, Sedat; Dizdar, Omer; Disel, Umut; Selcukbiricik, Fatih; Kose, Fatih; Olmez, Omer Fatih; Demir, Gokhan; Yalcin, Suayib; Bilici, Ahmet

Induction chemotherapy followed by definitive chemoradiation in patients with inoperable esophageal squamous cell carcinoma: a multicenter retrospective study

对无法手术的食管鳞状细胞癌患者进行诱导化疗后行根治性放化疗:一项多中心回顾性研究

Sahin, Taha Koray; Eroglu, Imdat; Dilli, Ismail; Sutcuoglu, Osman; Chalabiyev, Elvin; Guven, Deniz Can; Aktas, Burak Yasin; Kaya, Dilsa Mizrak; Ates, Ozturk; Ozdemir, Nuriye; Yalcin, Suayib; Dizdar, Omer

Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG)

转移性壶腹腺癌一线FOLFIRINOX方案与氟尿嘧啶类和吉西他滨类化疗方案的比较:土耳其肿瘤协作组(TOG)的多中心研究

Kalem, Ali; Kus, Tulay; Gokcek, Savas; Unek, Ilkay Tugba; Sahin, Taha Koray; Dizdar, Omer; Sagıroglu, Muhammed Fatih; Bolek, Hatice; Urun, Yuksel; Yaslıkaya, Sendag; Bayram, Ertugrul; Sever, Nadiye; Bayoğlu, Ibrahim Vedat; Acar, Omer; Erdogan, Atike Pınar; Saray, Seray; Karabuga, Berkan; Arslan Yalcıntas, Ulku; Efil, Safa Can; Sendur, Mehmet Ali Nahit; Aykut, Talat; Araz, Murat; Gunes, Tugce Kubra; Ozcelik, Melike; Seyyar, Mustafa; Aktas, Gokmen; Yalcın, Suayib

Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitors

白蛋白-肌脂肪变性指标作为免疫检查点抑制剂治疗患者的预后生物标志物

Sahin, Taha Koray; Guven, Deniz Can; Ozbay, Yakup; Atak, Firat; Arslan, Sevtap; İcli, Mehmet Cihan; Karahan, Latif; Kaygusuz, Yunus; Arik, Zafer; Dizdar, Omer; Erman, Mustafa; Yalcin, Suayib; Onur, Mehmet Ruhi; Aksoy, Sercan